US Stock MarketDetailed Quotes

RGC Regencell Bioscience

Watchlist
  • 4.920
  • -0.310-5.93%
Close Dec 20 16:00 ET
64.02MMarket Cap-14.91P/E (TTM)

Regencell Bioscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
(FY)Dec 31, 2017
(Q4)Dec 31, 2017
(Q3)Sep 30, 2017
(Q2)Jun 30, 2017
Total revenue
0
0
0
0
0
0
-1.07%3.16B
6.03%861.6M
-11.77%716M
-2.76%764.2M
Operating revenue
--0
--0
--0
--0
--0
--0
-1.07%3.16B
6.03%861.6M
-11.77%716M
-2.76%764.2M
Cost of revenue
-2.87%1.19B
6.24%323.7M
-13.69%264.9M
-6.41%289.1M
Gross profit
0.06%1.97B
5.91%537.9M
-10.60%451.1M
-0.40%475.1M
Operating expense
-24.50%4.74M
-17.64%6.27M
451.47%7.62M
70.04%1.38M
107.77%812.37K
390.99K
4.22%1.7B
8.31%447.2M
2.68%428.6M
3.92%416.1M
Selling and administrative expenses
-21.77%3.67M
-8.10%4.69M
441.40%5.11M
121.30%943.04K
161.81%426.14K
--162.77K
0.23%513.4M
0.23%128.8M
-0.70%126.9M
1.57%129.2M
-Selling and marketing expense
-52.25%125.43K
939.22%262.66K
1,503.74%25.28K
-98.62%1.58K
3,039.28%114.21K
--3.64K
----
----
----
----
-General and administrative expense
-19.96%3.55M
-12.81%4.43M
439.62%5.08M
201.81%941.46K
96.03%311.93K
--159.13K
0.23%513.4M
0.23%128.8M
-0.70%126.9M
1.57%129.2M
Research and development costs
-32.59%1.07M
-37.04%1.58M
473.13%2.51M
13.49%438.32K
69.23%386.23K
--228.22K
----
----
----
----
Depreciation amortization depletion
----
----
----
----
----
----
8.24%249.7M
6.54%63.5M
6.67%62.4M
10.54%62.9M
-Depreciation and amortization
----
----
----
----
----
----
8.24%249.7M
6.54%63.5M
6.67%62.4M
10.54%62.9M
Other operating expenses
----
----
----
----
----
----
3.33%912.6M
6.98%246.7M
0.49%227.4M
3.72%222.8M
Operating profit
24.50%-4.74M
17.64%-6.27M
-451.47%-7.62M
-70.04%-1.38M
-107.77%-812.37K
-390.99K
-19.95%271.7M
-4.53%90.7M
-74.20%22.5M
-22.98%59M
Net non-operating interest income expense
2.34%-125.1M
-0.64%-31.6M
0.63%-31.7M
3.72%-31.1M
Other net income (expense)
76.73%373.51K
810.37%211.34K
-32.94%23.22K
34.62K
-4.40%67.3M
-49.75%10.1M
104.94%33.2M
16.10%13.7M
Gain on sale of security
----
----
----
----
----
----
--17.8M
--0
--17.8M
----
Earnings from equity interest
----
----
----
----
----
----
-18.03%24.1M
25.89%-16.6M
-4.94%15.4M
12.78%15M
Special income (charges)
----
----
----
----
----
----
-400.00%-24M
-241.38%-8.2M
-147.92%-11.9M
20.00%-1.2M
-Less:Impairment of capital assets
----
----
----
----
----
----
400.00%24M
241.38%8.2M
147.92%11.9M
-20.00%1.2M
-Less:Other special charges
----
----
----
----
----
----
--0
--0
--0
--0
Other non- operating income (expenses)
76.73%373.51K
810.37%211.34K
-32.94%23.22K
--34.62K
----
----
----
----
----
----
Income before tax
28.03%-4.36M
20.18%-6.06M
-463.92%-7.59M
-65.78%-1.35M
-107.77%-812.37K
-390.99K
-24.07%213.9M
-17.32%69.2M
-66.43%24M
-25.85%41.6M
Income tax
0
0
0
0
0
0
-8.63%101.6M
35.23%40.3M
-56.85%12.6M
-20.00%18M
Net income
28.03%-4.36M
20.18%-6.06M
-463.92%-7.59M
-65.78%-1.35M
-107.77%-812.37K
-390.99K
-34.13%112.3M
-46.38%28.9M
-73.05%11.4M
-29.76%23.6M
Net income continuous Operations
28.03%-4.36M
20.18%-6.06M
-463.92%-7.59M
-65.78%-1.35M
-107.77%-812.37K
---390.99K
-34.13%112.3M
-46.38%28.9M
-73.05%11.4M
-29.76%23.6M
Minority interest income
67.90%-61.38K
-28.66%-191.2K
-148.61K
0
0
0
0
Net income attributable to the parent company
26.73%-4.3M
21.15%-5.87M
-452.88%-7.45M
-65.78%-1.35M
-107.77%-812.37K
-390.99K
-34.10%112.3M
-46.38%28.9M
-73.05%11.4M
-29.55%23.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
26.73%-4.3M
21.15%-5.87M
-452.88%-7.45M
-65.78%-1.35M
-107.77%-812.37K
-390.99K
-34.10%112.3M
-46.38%28.9M
-73.05%11.4M
-29.55%23.6M
Basic earnings per share
26.67%-0.33
22.41%-0.45
-444.45%-0.58
-65.78%-0.1065
-107.77%-0.0643
-0.0309
-33.94%0.72
-44.12%0.19
-74.07%0.07
-28.57%0.15
Diluted earnings per share
26.67%-0.33
22.41%-0.45
-444.45%-0.58
-65.78%-0.1065
-107.77%-0.0643
-0.0309
-33.94%0.72
-44.12%0.19
-74.07%0.07
-28.57%0.15
Dividend per share
0.00%0.88
0.00%0.22
0.00%0.22
0.00%0.22
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
(FY)Jun 30, 2024 (FY)Jun 30, 2023 (FY)Jun 30, 2022 (FY)Jun 30, 2021 (FY)Jun 30, 2020 (FY)Jun 30, 2019 (FY)Dec 31, 2017 (Q4)Dec 31, 2017 (Q3)Sep 30, 2017 (Q2)Jun 30, 2017
Total revenue 0 0 0 0 0 0 -1.07%3.16B 6.03%861.6M -11.77%716M -2.76%764.2M
Operating revenue --0 --0 --0 --0 --0 --0 -1.07%3.16B 6.03%861.6M -11.77%716M -2.76%764.2M
Cost of revenue -2.87%1.19B 6.24%323.7M -13.69%264.9M -6.41%289.1M
Gross profit 0.06%1.97B 5.91%537.9M -10.60%451.1M -0.40%475.1M
Operating expense -24.50%4.74M -17.64%6.27M 451.47%7.62M 70.04%1.38M 107.77%812.37K 390.99K 4.22%1.7B 8.31%447.2M 2.68%428.6M 3.92%416.1M
Selling and administrative expenses -21.77%3.67M -8.10%4.69M 441.40%5.11M 121.30%943.04K 161.81%426.14K --162.77K 0.23%513.4M 0.23%128.8M -0.70%126.9M 1.57%129.2M
-Selling and marketing expense -52.25%125.43K 939.22%262.66K 1,503.74%25.28K -98.62%1.58K 3,039.28%114.21K --3.64K ---- ---- ---- ----
-General and administrative expense -19.96%3.55M -12.81%4.43M 439.62%5.08M 201.81%941.46K 96.03%311.93K --159.13K 0.23%513.4M 0.23%128.8M -0.70%126.9M 1.57%129.2M
Research and development costs -32.59%1.07M -37.04%1.58M 473.13%2.51M 13.49%438.32K 69.23%386.23K --228.22K ---- ---- ---- ----
Depreciation amortization depletion ---- ---- ---- ---- ---- ---- 8.24%249.7M 6.54%63.5M 6.67%62.4M 10.54%62.9M
-Depreciation and amortization ---- ---- ---- ---- ---- ---- 8.24%249.7M 6.54%63.5M 6.67%62.4M 10.54%62.9M
Other operating expenses ---- ---- ---- ---- ---- ---- 3.33%912.6M 6.98%246.7M 0.49%227.4M 3.72%222.8M
Operating profit 24.50%-4.74M 17.64%-6.27M -451.47%-7.62M -70.04%-1.38M -107.77%-812.37K -390.99K -19.95%271.7M -4.53%90.7M -74.20%22.5M -22.98%59M
Net non-operating interest income expense 2.34%-125.1M -0.64%-31.6M 0.63%-31.7M 3.72%-31.1M
Other net income (expense) 76.73%373.51K 810.37%211.34K -32.94%23.22K 34.62K -4.40%67.3M -49.75%10.1M 104.94%33.2M 16.10%13.7M
Gain on sale of security ---- ---- ---- ---- ---- ---- --17.8M --0 --17.8M ----
Earnings from equity interest ---- ---- ---- ---- ---- ---- -18.03%24.1M 25.89%-16.6M -4.94%15.4M 12.78%15M
Special income (charges) ---- ---- ---- ---- ---- ---- -400.00%-24M -241.38%-8.2M -147.92%-11.9M 20.00%-1.2M
-Less:Impairment of capital assets ---- ---- ---- ---- ---- ---- 400.00%24M 241.38%8.2M 147.92%11.9M -20.00%1.2M
-Less:Other special charges ---- ---- ---- ---- ---- ---- --0 --0 --0 --0
Other non- operating income (expenses) 76.73%373.51K 810.37%211.34K -32.94%23.22K --34.62K ---- ---- ---- ---- ---- ----
Income before tax 28.03%-4.36M 20.18%-6.06M -463.92%-7.59M -65.78%-1.35M -107.77%-812.37K -390.99K -24.07%213.9M -17.32%69.2M -66.43%24M -25.85%41.6M
Income tax 0 0 0 0 0 0 -8.63%101.6M 35.23%40.3M -56.85%12.6M -20.00%18M
Net income 28.03%-4.36M 20.18%-6.06M -463.92%-7.59M -65.78%-1.35M -107.77%-812.37K -390.99K -34.13%112.3M -46.38%28.9M -73.05%11.4M -29.76%23.6M
Net income continuous Operations 28.03%-4.36M 20.18%-6.06M -463.92%-7.59M -65.78%-1.35M -107.77%-812.37K ---390.99K -34.13%112.3M -46.38%28.9M -73.05%11.4M -29.76%23.6M
Minority interest income 67.90%-61.38K -28.66%-191.2K -148.61K 0 0 0 0
Net income attributable to the parent company 26.73%-4.3M 21.15%-5.87M -452.88%-7.45M -65.78%-1.35M -107.77%-812.37K -390.99K -34.10%112.3M -46.38%28.9M -73.05%11.4M -29.55%23.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 26.73%-4.3M 21.15%-5.87M -452.88%-7.45M -65.78%-1.35M -107.77%-812.37K -390.99K -34.10%112.3M -46.38%28.9M -73.05%11.4M -29.55%23.6M
Basic earnings per share 26.67%-0.33 22.41%-0.45 -444.45%-0.58 -65.78%-0.1065 -107.77%-0.0643 -0.0309 -33.94%0.72 -44.12%0.19 -74.07%0.07 -28.57%0.15
Diluted earnings per share 26.67%-0.33 22.41%-0.45 -444.45%-0.58 -65.78%-0.1065 -107.77%-0.0643 -0.0309 -33.94%0.72 -44.12%0.19 -74.07%0.07 -28.57%0.15
Dividend per share 0.00%0.88 0.00%0.22 0.00%0.22 0.00%0.22
Currency Unit USD USD USD USD USD USD USD USD USD USD
Audit Opinions Unqualified Opinion Unqualified Opinion Unqualified Opinion Unqualified Opinion Unqualified Opinion with Explanatory Notes -- -- -- -- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List